SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BioStem Technologies Expands Patent Protection for Placental Allograft and Umbilical Tissue Tech

BioStem Technologies has enhanced its patent portfolio with a newly issued U.S. patent and pending allowances in the U.S. and Mexico. These protections cover the company's sterile placental allograft, micronized wound care, and umbilical cord extract technologies.

BSEM

Related stories